Argenx
ARGX
#501
Rank
C$57.10 B
Marketcap
$955.07
Share price
-0.72%
Change (1 day)
88.36%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): -$5.59

According to Argenx 's latest financial reports the company's current EPS (TTM) is -$5.97. In 2022 the company made an earnings per share (EPS) of -$18.83.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$5.59-70.3%
2022-$18.83